The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RLAY FINANCIAL STATEMENTS

Relay Therapeutics Inc — balance sheet, income statement and cash flow trends

RLAYRelay Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-400 M-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue10.4 M $Gross Profit-58.6 M $ · -567%Operating Income-310.4 M $ · -2999%Pre-tax Income-286 M $ · -2764%Net Income to Owners-286 M $ · -2764%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue10.4 M $+23.9%
Gross Profit-58.6 M $—
Operating Income-310.4 M $—
EBITDA-286.9 M $—
Net Income to Owners-286 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets967.5 M
  • Equity890 M $92%
  • Current Liabilities50.8 M $5%
  • Long-term Liabilities26.6 M $3%

Key Figures

YoY change
Total Assets967.5 M $+32.7%
Total Liabilities77.4 M $+22.6%
Total Equity890 M $+33.7%
Cash & ST Investments910.9 M $+38.7%
Total Debt30.7 M $-10.3%
Net Debt-90.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-300 M-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-212.2 M $Operating-244.9 M $Investing463.5 M $Financing6.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-212.2 M $—
Capital Expenditures2 K $-99.7%
Free Cash Flow-212.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RLAY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.